Tariffs on imports from China are raising concerns about potential pharmaceutical shortages in the U.S., as a significant portion of medications, including 95% of ibuprofen, originate from China. Industry experts warn that these trade tensions could disrupt supply chains and impact healthcare accessibility.
— new from Fortune
